COMPASS Pathways Plc (CMPS)

[Fress]

Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline


$CMPS